Assessing the global poverty effects of antimicrobial resistance

•By 2050 there may be 28.3 million more people living below PPP $1.90/day, 26.2 million of those in low-income countries.•Expected losses from AMR in 2015–50 may sum to $85 trillion in GDP and $23 trillion in global trade (in present value).•By 2050, global GDP could deviate negatively by 3.8 percen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World development 2018-11, Vol.111, p.148-160
Hauptverfasser:	Ahmed, Syud Amer, Barış, Enis, Go, Delfin S., Lofgren, Hans, Osorio-Rodarte, Israel, Thierfelder, Karen
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiinfectives and antibacterials Antimicrobial agents Antimicrobial resistance Clinical outcomes Cost assessments Drug resistance Dynamic computable general equilibrium modeling Economic conditions Economic growth of open economies Economics Employment Exports GDP Global economy Gross Domestic Product Health (pandemics) Health care expenditures Health care policy Impact analysis Income International cooperation Labor productivity Livestock Low income groups Macroeconomics Measurement and analysis of poverty Mortality Pandemics Poverty Present value Productivity Resilience Resistance Trade flows Wage & price controls
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!